18442977_1|18442977|25979|#section_info|0:0|As shown in Fig. 4 (A and B), application of 8-OH-DPAT (40 mum, 20 min) caused a potent increase in free tubulin (1.7 +- 0.3-fold increase, n = 3, p < 0.001, ANOVA), however, this effect was significantly blocked by alpha-Me-5HT (20 mum, 0.6 +- 0.2-fold increase, n = 3), indicating that 5-HT2 activation could increase microtubule stability and prevent 5-HT1A-induced microtubule depolymerization.|#main_body|GO:0007026|negative regulation of microtubule depolymerization|Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.|IDA|GOA|htr1a(24473)|#gene_synonym
18442977_2|18442977|25979|#section_info|0:0|As shown in Fig. 4 (A and B), application of 8-OH-DPAT (40 mum, 20 min) caused a potent increase in free tubulin (1.7 +- 0.3-fold increase, n = 3, p < 0.001, ANOVA), however, this effect was significantly blocked by alpha-Me-5HT (20 mum, 0.6 +- 0.2-fold increase, n = 3), indicating that 5-HT2 activation could increase microtubule stability and prevent 5-HT1A-induced microtubule depolymerization.|#main_body|GO:0007026|negative regulation of microtubule depolymerization|Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.|IDA|GOA|htr1a(24473)|#gene_synonym
18442977_3|18442977|25979|#section_info|0:0|application of 8-OH-DPAT (40 mum, 20 min) caused a potent increase in free tubulin (1.7 +- 0.3-fold increase, n = 3, p < 0.001, ANOVA), however, this effect was significantly blocked by alpha-Me-5HT (20 mum, 0.6 +- 0.2-fold increase, n = 3), indicating that 5-HT2 activation could increase microtubule stability and prevent 5-HT1A-induced microtubule depolymerization.|#main_body|GO:0007026|negative regulation of microtubule depolymerization|Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.|IDA|GOA|htr1a(24473)|#gene_synonym
18442977_4|18442977|25979|#section_info|0:0|As shown in Fig. 4 (A and B), application of 8-OH-DPAT (40 mum, 20 min) caused a potent increase in free tubulin (1.7 +- 0.3-fold increase, n = 3, p < 0.001, ANOVA), however, this effect was significantly blocked by alpha-Me-5HT (20 mum, 0.6 +- 0.2-fold increase, n = 3), indicating that 5-HT2 activation could increase microtubule stability and prevent 5-HT1A-induced microtubule depolymerization.|#main_body|GO:0007026|negative regulation of microtubule depolymerization|Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.|IDA|GOA|htr1a(24473)|#gene_synonym
18442977_5|18442977|27012|#section_info|0:0|As shown in Fig. 4 (C and D), bath application of the microtubule depolymerizer, colchicine (30 mum), gradually reduced NMDAR-EPSC in PFC slices (38.0 +- 2.9%, n = 5, also see Ref. 22), mimicking and occluding the 5-HT1A effect (21). However, this inhibitory effect of colchicine was largely attenuated in the presence of alpha-Me-5HT (20 mum, 11.2 +- 13.4%, n = 6).|#main_body|GO:0007026|negative regulation of microtubule depolymerization|Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.|IDA|GOA|htr1a(24473)|#gene_synonym
18442977_6|18442977|27012|#section_info|0:0|As shown in Fig. 4 (C and D), bath application of the microtubule depolymerizer, colchicine (30 mum), gradually reduced NMDAR-EPSC in PFC slices (38.0 +- 2.9%, n = 5, also see Ref. 22), mimicking and occluding the 5-HT1A effect (21).|#main_body|GO:0007026|negative regulation of microtubule depolymerization|Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.|IDA|GOA|htr1a(24473)|#gene_synonym
